Cullinan Therapeutics, Inc.

US$11.31As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:CGEMHealthcare
Country USA
PE (Fwd) •••
TSR 6Y CAGR (18.95%)
Div yield —
ROE (50.30%)
Biotechnology
Beta (5Y) (0.06)
PE TTM —
TSR TTM 30.60%
Mkt cap US$727.9M
ROIC (212.89%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$11
(1.73%)
288.12%
Hold 6|0|1|12|3
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.16
0.16
0.16
0.15
7.41%
13.62%
15.51%
6.55%
Revenue$M
67.89
70.96
69.53
67.91
4.66%
10.55%
4.82%
0.01%
Peers (US$727.9M)
Cap (US$)
PE
733.7M
—
724.0M
—
723.1M
4.629x
Capital
TTM
5Y
10Y
Leveragex
1.478
2.055
1.368
EBIT/Intx
0.405
0.603
0.623
Own earn%
27.06
(138.83)
(124.78)
Sh yield%
51.91
31.76
32.37
Owners
Insiders/Inst%
8.05
58.41
Short interest%
0.65
SBC / revenue%
5.11
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
21
Op margin range%
4–8
$1 testx
—
Incr. ROIC%
5